ZOLGENSMA INTHIA Trademark
Trademark Overview
On Thursday, January 18, 2024, a trademark application was filed for ZOLGENSMA INTHIA with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA INTHIA trademark a serial number of 79392147. The federal status of this trademark filing is PRIORITY ACTION COUNTED NOT MAILED as of Monday, December 16, 2024. This trademark is owned by NOVARTIS AG. The ZOLGENSMA INTHIA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
General Information
| Serial Number | 79392147 |
| Word Mark | ZOLGENSMA INTHIA |
| Filing Date | Thursday, January 18, 2024 |
| Status | 657 - PRIORITY ACTION COUNTED NOT MAILED |
| Status Date | Monday, December 16, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Thursday, March 28, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, April 2, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, April 8, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, December 16, 2024 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, December 16, 2024 | PRIORITY ACTION WRITTEN |
| Monday, December 16, 2024 | PRIORITY ACTION E-MAILED |
| Friday, March 29, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 8, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, April 8, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 8, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, April 8, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 8, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, August 9, 2024 | ASSIGNED TO EXAMINER |
| Friday, January 3, 2025 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Tuesday, December 17, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
